Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Veradigm Inc. - common stock (OP: MDRX )

9.050 -0.050 (-0.55%)
Streaming Delayed Price Updated: 9:30 AM EST, Jan 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Veradigm Inc. - common stock

Glancy Prongay & Murray LLP Announces Investigation of Veradigm Inc. (MDRX)
From Glancy Prongay & Murray LLP
Via Business Wire
Veradigm Launches an Ambient Scribe Advancement to Ease the Healthcare Administrative Burden
From Veradigm
Via Business Wire
Veradigm Advancing Point of Care Engagement Through Payer-Provider Collaboration
From Veradigm
Via Business Wire
Veradigm Advances Deeper Clinical Insights Through NLP-Enhanced EHR Data
From Veradigm
Via Business Wire
Automated Medical Chart Retrieval Expands to 300,000+ U.S. Healthcare Providers via Veradigm eChart Courier
From Veradigm
Via Business Wire
Veradigm Ranked Top Vendor by KLAS
From Veradigm
Via Business Wire
Veradigm Named as the Top Vendor for End-to-End Revenue Cycle Management Solutions
From Veradigm
Via Business Wire
Positive Impact Observed at Many Orthopedic Practices Utilizing Veradigm Coding Services
From Veradigm
Via Business Wire
Black Book ranks Veradigm Payer Analytics the #1 Overall Payer Analytics Solutions Vendor in 2024
From Veradigm
Via Business Wire
Robbins LLP Reminds MDRX Stockholders it is Investigating the Officers and Directors of Veradigm Inc. to Determine if They Breached Fiduciary Duties Owed to Shareholders
From Robbins LLP
Via Business Wire
Robbins LLP Informs Investors it is Investigating the Officers and Directors of Veradigm Inc. (MDRX) for Breaches of Fiduciary Duty
From Robbins LLP
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.